Shrestha Sweta, Wang Bo, Dutta Prabir K
ZeoVation Inc., Columbus, OH 43212, USA.
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA.
Antibiotics (Basel). 2024 Sep 23;13(9):910. doi: 10.3390/antibiotics13090910.
Chronic wounds are a major health problem because of delayed healing, causing hardships for the patient. The infection present in these wounds plays a role in delayed wound healing. Silver wound dressings have been used for decades, beginning in the 1960s with silver sulfadiazine for infection prevention for burn wounds. Since that time, there has been a large number of commercial silver dressings that have obtained FDA clearance. In this review, we examine the literature involving in vitro and in vivo (both animal and human clinical) studies with commercial silver dressings and attempt to glean the important characteristics of these dressings in treating infected wounds. The primary presentation of the literature is in the form of detailed tables. The narrative part of the review focuses on the different types of silver dressings, including the supporting matrix, the release characteristics of the silver into the surroundings, and their toxicity. Though there are many clinical studies of chronic and burn wounds using silver dressings that we discuss, it is difficult to compare the performances of the dressings directly because of the differences in the study protocols. We conclude that silver dressings can assist in wound healing, although it is difficult to provide general treatment guidelines. From a wound dressing point of view, future studies will need to focus on new delivery systems for silver, as well as the type of matrix in which the silver is deposited. Clearly, adding other actives to enhance the antimicrobial activity, including the disruption of mature biofilms is of interest. From a clinical point of view, the focus needs to be on the wound healing characteristics, and thus randomized control trials will provide more confidence in the results. The application of different wound dressings for specific wounds needs to be clarified, along with the application protocols. It is most likely that no single silver-based dressing can be used for all wounds.
慢性伤口是一个重大的健康问题,因其愈合延迟,给患者带来诸多不便。这些伤口中存在的感染在伤口愈合延迟中起作用。银质伤口敷料已经使用了几十年,始于20世纪60年代的磺胺嘧啶银用于预防烧伤伤口感染。从那时起,有大量已获得美国食品药品监督管理局(FDA)批准的商用银质敷料。在本综述中,我们研究了涉及商用银质敷料的体外和体内(动物和人体临床)研究的文献,并试图梳理出这些敷料在治疗感染伤口方面的重要特性。文献的主要呈现形式为详细表格。综述的叙述部分聚焦于不同类型的银质敷料,包括支撑基质、银向周围环境的释放特性及其毒性。尽管我们讨论了许多使用银质敷料治疗慢性和烧伤伤口的临床研究,但由于研究方案的差异,很难直接比较这些敷料的性能。我们得出结论,银质敷料有助于伤口愈合,尽管难以提供通用的治疗指南。从伤口敷料的角度来看,未来的研究需要关注银的新递送系统,以及银所沉积的基质类型。显然,添加其他活性物质以增强抗菌活性,包括破坏成熟生物膜,是值得关注的。从临床角度来看,重点需要放在伤口愈合特性上,因此随机对照试验将使结果更具可信度。需要明确针对特定伤口应用不同伤口敷料的情况以及应用方案。很可能没有一种单一的银基敷料可用于所有伤口。